BCI‐838, an orally active mGluR2/3 antagonist pro‐drug, mimics the beneficial effects of physical exercise on neurogenesis, behavior and exercise‐related molecular pathways in an Alzheimer's disease mouse model. - Bicak, Mesude; Perez‐Garcia, Georgina E.; Buros, Jacqueline; Haure‐Mirande, Jean‐Vianney; Perez, Gissel E.; Otero‐Pagan, Alena; Gama‐Sosa, Miguel E.; DeGasperi, Rita E.; Sano, Mary; Gage, Fred H.; Barlow, Carrolee; Dudley, Joel; et al. (Alzheimer's & dementia: the journal of the Alzheimer's Association, 2022)